A new $3.3 million grant from the Bristol Myers Squibb Foundation has been awarded to the Georgia Cancer Center in an effort to impact cancer statistics for African Americans in urban and rural minority underserved areas of the state.
September is Prostate Cancer Awareness Month, and the Georgia Cancer Center aims to raise awareness about this disease.
It is the most common form of cancer found in men. And, while it is likely the prostate cancer growing inside your body will grow slowly, that does not mean it is time to skip a screening or follow-up appointment with your primary care provider.
A group of oncologists from across the world, including Dr. Zach Klaassen of the Georgia Cancer Center, came together to develop guidelines for patients diagnosed with prostate, testicular and other genitourinary cancers during the COVID-19 pandemic.
A robot, its human assistant and a team of surgery specialists are the first in the United States to perform three complex cancer surgeries in one setting using the same anesthesia.
There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.
A transcription factor that aids neuron function also appears to enable a cell conversion in the prostate gland that can make an already recurrent cancer even more deadly, scientists say.
The Georgia Cancer Center at Augusta University and the Center for Cancer Research and Therapeutic Development at Clark Atlanta University have created a collaborative partnership aimed at researching prostate cancer and positive patient outcomes.
According to the American Cancer Society, prostate cancer is the second most common cancer diagnosed in men. ACS research shows about one in nine men will be diagnosed with prostate cancer at some point during their lifetime.
Dr. Martha Terris has a message for men, diagnosed with prostate cancer, who are not worried about follow-up visits with their oncologist.
They dazzle audiences with their moves, their energy and their ability to score in the most unusual ways. Now, the Harlem Legends are bringing their skills to Augusta to raise money for the Georgia Cancer Center at Augusta University.
Breast cancer, prostate cancer, lung cancer… three of the more common cancers diagnosed in the country. But even with all of those patients living in America, it would be tough to find people who aren’t feeling alone in the fight for their life...
Dr. Rabii Madi, director of Urologic Oncology and Robotic Surgery at the Georgia Cancer Center, believes the Retzius-Sparing method for prostate cancer surgery can help men get back to a normal routine faster than tradition surgery. The benefits...
A male breast cancer survivor wants to make sure his fellow men have access to the treatment options needed to win their own fight against cancer. Cecil Herrin joined leaders from the Georgia Cancer Center Thursday to donate $52,134.15 raised during...
While it’s widely held that tumors can produce blood vessels to support their growth, scientists now have evidence that cells key to blood vessel formation can also produce tumors and enable their spread. “Today we actually propose that blood...
This weekend, families across the country will celebrate “dad” with funny cards, gifts and plenty of food, too. And while it’s all fun and games now, it may also be the perfect time to talk about your dad’s health. That’s because a group monitoring...
In this week’s Medical Minute, Dr. Joseph Hobbs, chairman of the Department of Family Medicine at the Medical College of Georgia at Augusta University, discusses how too much of a protein already associated with prostate cancer appears to have...
AUGUSTA, Ga. – Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report. Their studies of the protein Id1 also show high levels reduce conversion of unhealthy...
The Georgia Cancer Center at Augusta University is one of a dozen sites across the nation helping build a molecular profile of six cancers that often strike early and disparately.
A poorly understood gene that appears super-suppressed in African-Americans with kidney cancer may be a biomarker of a patient’s prognosis and a new target for improving it, researchers say. Renal cell carcinoma is the most common type of kidney...